{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:33:46Z","timestamp":1778078026795,"version":"3.51.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12265-022-10268-3","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T20:08:43Z","timestamp":1653077323000},"page":"1219-1238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dual Specific Phosphatase 7 Exacerbates Dilated Cardiomyopathy, Heart Failure, and Cardiac Death by Inactivating the ERK1\/2 Signaling Pathway"],"prefix":"10.1007","volume":"15","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-3406","authenticated-orcid":false,"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"issue":"6","key":"10268_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehaa1061","volume":"42","author":"H Bueno","year":"2021","unstructured":"Bueno, H., Moura, B., Lancellotti, P., & Bauersachs, J. (2021). The year in cardiovascular medicine 2020: heart failure and cardiomyopathies. European Heart Journal, 42(6), 657\u2013670. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1061","journal-title":"European Heart Journal"},{"issue":"Pt. 3","key":"10268_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/bj20040498","volume":"383","author":"K Takagaki","year":"2004","unstructured":"Takagaki, K., Satoh, T., Tanuma, N., Masuda, K., Takekawa, M., Shima, H., et al. (2004). Characterization of a novel low-molecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38.\u00a0Biochemical Journal,383(Pt. 3), 447\u2013455. https:\/\/doi.org\/10.1042\/bj20040498","journal-title":"Biochem J"},{"issue":"1","key":"10268_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1471-4159.2006.03852.x","volume":"98","author":"JY Wang","year":"2006","unstructured":"Wang, J. Y., Lin, C. H., Yang, C. H., Tan, T. H., & Chen, Y. R. (2006). Biochemical and biological characterization of a neuroendocrine-associated phosphatase.\u00a0Journal of Neurochemistry,\u00a098(1), 89\u2013101. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03852.x","journal-title":"J Neurochem"},{"issue":"2","key":"10268_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1042\/CS20160664","volume":"131","author":"WM Li","year":"2017","unstructured":"Li, W. M., Zhao, Y. F., Zhu, G. F., Peng, W. H., Zhu, M. Y., Yu, X. J., et al. (2017). Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload.\u00a0Clinical Science(London), 131(2), 141\u2013154. https:\/\/doi.org\/10.1042\/CS20160664","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10268_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1742-4658.2012.08716.x","volume":"280","author":"CJ Caunt","year":"2013","unstructured":"Caunt, C. J., & Keyse, S. M. (2013). Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling.\u00a0FEBS Journal, 280(2), 489\u2013504. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08716.x","journal-title":"FEBS J"},{"issue":"4","key":"10268_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10038-005-0235-y","volume":"50","author":"S Xu","year":"2005","unstructured":"Xu, S., Furukawa, T., Kanai, N., Sunamura, M., & Horii, A. (2005). Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.\u00a0Journal of Human Genetics, 50(4), 159\u2013167. https:\/\/doi.org\/10.1007\/s10038-005-0235-y","journal-title":"J Hum Genet"},{"issue":"7","key":"10268_CR7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/s0016-5085(03)00398-6","volume":"124","author":"Q Liao","year":"2003","unstructured":"Liao, Q., Guo, J., Kleeff, J., Zimmermann, A., B\u00fcchler, M. W., Korc, M., et al. (2003). Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology, 124(7), 1830\u20131845. https:\/\/doi.org\/10.1016\/s0016-5085(03)00398-6","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"10268_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/a:1006980326855","volume":"199","author":"S Srikanth","year":"1999","unstructured":"Srikanth, S., Franklin, C. C., Duke, R. C., & Kraft, R. S. (1999). Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis.\u00a0Molecular and Cellular Biochemistry, 199(1\u20132), 169\u2013178. https:\/\/doi.org\/10.1023\/a:1006980326855","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10268_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/1097-0215(200002)9999:9999<::aid-ijc1036>3.3.co;2-d","volume":"91","author":"RG Weber","year":"2001","unstructured":"Weber, R. G., Rieger, J., Naumann, U., Lichter, P., & Weller, M. (2001). Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines.\u00a0International Journal of Cancer, 91(2), 213\u2013218. https:\/\/doi.org\/10.1002\/1097-0215(200002)9999:9999%3c::aid-ijc1036%3e3.3.co;2-d","journal-title":"Int J Cancer"},{"issue":"1","key":"10268_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/bbrc.1998.9256","volume":"250","author":"YJ Bang","year":"1998","unstructured":"Bang, Y. J., Kwon, J. H., Kang, S. H., Kim, J. W., & Yang, Y. C. (1998). Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma.\u00a0Biochemical and Biophysical Research Communications, 250(1), 43\u201347. https:\/\/doi.org\/10.1006\/bbrc.1998.9256","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10268_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ygyno.2004.03.009","volume":"93","author":"V Givant-Horwitz","year":"2004","unstructured":"Givant-Horwitz, V., Davidson, B., Goderstad, J. M., Nesland, J. M., Trop\u00e9, C. G., & Reich, R. (2004). The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.\u00a0Gynecologic Oncology, 93(2), 517\u2013523. https:\/\/doi.org\/10.1016\/j.ygyno.2004.03.009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10268_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/circresaha.112.272963","volume":"112","author":"M Auger-Messier","year":"2013","unstructured":"Auger-Messier, M., Accornero, F., Goonasekera, S. A., Bueno, O. F., Lorenz, J. N., van Berlo, J. H., et al. (2013). Unrestrained p38 MAPK activation in Dusp1\/4 double-null mice induces cardiomyopathy.\u00a0Circulation Research, 112(1), 48\u201356. https:\/\/doi.org\/10.1161\/circresaha.112.272963","journal-title":"Circ Res"},{"issue":"45","key":"10268_CR13","doi-asserted-by":"publisher","first-page":"31246","DOI":"10.1074\/jbc.M806085200","volume":"283","author":"M Maillet","year":"2008","unstructured":"Maillet, M., Purcell, N. H., Sargent, M. A., York, A. J., Bueno, O. F., & Molkentin, J. D. (2008). DUSP6 (MKP3) null mice show enhanced ERK1\/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility.\u00a0Journal of Biological Chemistry, 283(45), 31246\u201331255. https:\/\/doi.org\/10.1074\/jbc.M806085200","journal-title":"J Biol Chem"},{"issue":"2","key":"10268_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/circresaha.115.308238","volume":"119","author":"R Liu","year":"2016","unstructured":"Liu, R., van Berlo, J. H., York, A. J., Vagnozzi, R. J., Maillet, M., & Molkentin, J. D. (2016). DUSP8 Regulates Cardiac Ventricular Remodeling by Altering ERK1\/2 Signaling.\u00a0Circulation Research, 119(2), 249\u2013260. https:\/\/doi.org\/10.1161\/circresaha.115.308238","journal-title":"Circ Res"},{"issue":"2","key":"10268_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0304-3835(03)00352-5","volume":"199","author":"O Levy-Nissenbaum","year":"2003","unstructured":"Levy-Nissenbaum, O., Sagi-Assif, O., Raanani, P., Avigdor, A., Ben-Bassat, I., & Witz, I. P. (2003). Overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukaemia. Cancer Letters, 199(2), 185\u2013192. https:\/\/doi.org\/10.1016\/s0304-3835(03)00352-5","journal-title":"Cancer Letters"},{"issue":"1","key":"10268_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/dvdy.21380","volume":"237","author":"LD Urness","year":"2008","unstructured":"Urness, L. D., Li, C., Wang, X., & Mansour, S. L. (2008). Expression of ERK signaling inhibitors Dusp6, Dusp7, and Dusp9 during mouse ear development.\u00a0Developmental Dynamics, 237(1), 163\u2013169. https:\/\/doi.org\/10.1002\/dvdy.21380","journal-title":"Dev Dyn"},{"issue":"5","key":"10268_CR17","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.celrep.2016.10.007","volume":"17","author":"T Tischer","year":"2016","unstructured":"Tischer, T., & Schuh, M. (2016). The phosphatase Dusp7 drives meiotic resumption and chromosome alignment in mouse oocytes.\u00a0Cell Reports, 17(5), 1426\u20131437. https:\/\/doi.org\/10.1016\/j.celrep.2016.10.007","journal-title":"Cell Rep"},{"issue":"3","key":"10268_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12574-010-0078-1","volume":"9","author":"S Singh","year":"2011","unstructured":"Singh, S., Koyalakonda, S. P., & Krishnan, U. (2011). Severe dilated cardiomyopathy resulting in a globular cardiac silhouette on chest X-ray. Journal of Echocardiography, 9(3), 123\u2013124. https:\/\/doi.org\/10.1007\/s12574-010-0078-1","journal-title":"Journal of Echocardiography"},{"issue":"10","key":"10268_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/bf02599031","volume":"11","author":"RG Badgett","year":"1996","unstructured":"Badgett, R. G., Mulrow, C. D., Otto, P. M., & Ram\u00edrez, G. (1996). How well can the chest radiograph diagnose left ventricular dysfunction?\u00a0Journal of General Internal Medicine, 11(10), 625\u2013634. https:\/\/doi.org\/10.1007\/bf02599031","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10268_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.115.002314","volume":"9","author":"CL Organ","year":"2016","unstructured":"Organ, C. L., Otsuka, H., Bhushan, S., Wang, Z., Bradley, J., Trivedi, R., et al. (2016). Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure.\u00a0Circulatory\u00a0Heart\u00a0Failure, 9(1), e002314. https:\/\/doi.org\/10.1161\/circheartfailure.115.002314","journal-title":"Circ Heart Fail"},{"key":"10268_CR21","doi-asserted-by":"publisher","unstructured":"Makarewich, C. A., Munir, A. Z., Schiattarella, G. G., Bezprozvannaya, S., Raguimova, O. N., Cho, E. E., et al. (2018). The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy. Elife, 7. https:\/\/doi.org\/10.7554\/eLife.38319","DOI":"10.7554\/eLife.38319"},{"issue":"suppl_D","key":"10268_CR22","doi-asserted-by":"publisher","first-page":"D66","DOI":"10.1016\/j.ehjsup.2004.05.019","volume":"6","author":"B Pieske","year":"2004","unstructured":"Pieske, B. (2004). Reverse remodeling in heart failure \u2013 fact or fiction? European Heart Journal Supplements, 6(suppl_D), D66\u2013D78. https:\/\/doi.org\/10.1016\/j.ehjsup.2004.05.019","journal-title":"European Heart Journal Supplements"},{"issue":"1","key":"10268_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1161\/01.res.75.1.105","volume":"75","author":"JR Teerlink","year":"1994","unstructured":"Teerlink, J. R., Pfeffer, J. M., & Pfeffer, M. A. (1994). Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats.\u00a0Circulation Research, 75(1), 105\u2013113. https:\/\/doi.org\/10.1161\/01.res.75.1.105","journal-title":"Circ Res"},{"key":"10268_CR24","doi-asserted-by":"publisher","unstructured":"The Gene Ontology resource: enriching a GOld mine (2021). Nucleic Acids Research, 49(D1), D325-D334, doi:https:\/\/doi.org\/10.1093\/nar\/gkaa1113.","DOI":"10.1093\/nar\/gkaa1113"},{"issue":"Database issue","key":"10268_CR25","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkm882","volume":"36","author":"M Kanehisa","year":"2008","unstructured":"Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., et al. (2008). KEGG for linking genomes to life and the environment. Nucleic Acids Research, 36(Database issue), D480-484. https:\/\/doi.org\/10.1093\/nar\/gkm882","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10268_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12881-020-01088-w","volume":"21","author":"HP Widyastuti","year":"2020","unstructured":"Widyastuti, H. P., Norden-Krichmar, T. M., Grosberg, A., & Zaragoza, M. V. (2020). Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis.\u00a0BMC Medical Genomics, 21(1), 152. https:\/\/doi.org\/10.1186\/s12881-020-01088-w","journal-title":"BMC Med Genet"},{"issue":"6","key":"10268_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130477","volume":"10","author":"E Cipolletta","year":"2015","unstructured":"Cipolletta, E., Rusciano, M. R., Maione, A. S., Santulli, G., Sorriento, D., Del Giudice, C., et al. (2015). Targeting the CaMKII\/ERK interaction in the Heart prevents cardiac hypertrophy. PLoS One, 10(6), e0130477. https:\/\/doi.org\/10.1371\/journal.pone.0130477","journal-title":"PLoS One"},{"issue":"1","key":"10268_CR28","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1038\/s41467-020-18165-6","volume":"11","author":"ED Luczak","year":"2020","unstructured":"Luczak, E. D., Wu, Y., Granger, J. M., Joiner, M. A., Wilson, N. R., Gupta, A., et al. (2020). Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy.\u00a0Nature Communications, 11(1), 4416. https:\/\/doi.org\/10.1038\/s41467-020-18165-6","journal-title":"Nat Commun"},{"issue":"2","key":"10268_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1054\/jcaf.2002.32755","volume":"8","author":"C Communal","year":"2002","unstructured":"Communal, C., Colucci, W. S., Remondino, A., Sawyer, D. B., Port, J. D., Wichman, S. E., et al. (2002). Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium.\u00a0Journal of Cardiac Failure, 8(2), 86\u201392. https:\/\/doi.org\/10.1054\/jcaf.2002.32755","journal-title":"J Card Fail"},{"issue":"17","key":"10268_CR30","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.1074\/jbc.R117.777318","volume":"292","author":"R Newton","year":"2017","unstructured":"Newton, R., Shah, S., Altonsy, M. O., & Gerber, A. N. (2017). Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.\u00a0Journal of Biological Chemistry, 292(17), 7163\u20137172. https:\/\/doi.org\/10.1074\/jbc.R117.777318","journal-title":"J Biol Chem"},{"issue":"7","key":"10268_CR31","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1210\/en.2011-0021","volume":"152","author":"L Brion","year":"2011","unstructured":"Brion, L., Maloberti, P. M., Gomez, N. V., Poderoso, C., Gorostizaga, A. B., Mori Sequeiros Garcia, M. M., et al. (2011). MAPK phosphatase-1 (MKP-1) expression is up-regulated by hCG\/cAMP and modulates steroidogenesis in MA-10 Leydig cells. Endocrinology, 152(7), 2665\u20132677. https:\/\/doi.org\/10.1210\/en.2011-0021","journal-title":"Endocrinology"},{"issue":"2","key":"10268_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1074\/jbc.M508720200","volume":"281","author":"YW Lin","year":"2006","unstructured":"Lin, Y. W., & Yang, J. L. (2006). Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling.\u00a0Journal of Biological Chemistry, 281(2), 915\u2013926. https:\/\/doi.org\/10.1074\/jbc.M508720200","journal-title":"J Biol Chem"},{"issue":"10","key":"10268_CR33","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1210\/en.2009-1483","volume":"151","author":"KA Nguyen","year":"2010","unstructured":"Nguyen, K. A., Intriago, R. E., Upadhyay, H. C., Santos, S. J., Webster, N. J., & Lawson, M. A. (2010). Modulation of gonadotropin-releasing hormone-induced extracellular signal-regulated kinase activation by dual-specificity protein phosphatase 1 in LbetaT2 gonadotropes. Endocrinology, 151(10), 4882\u20134893. https:\/\/doi.org\/10.1210\/en.2009-1483","journal-title":"Endocrinology"},{"issue":"Pt 2","key":"10268_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/bj3230313","volume":"323","author":"SJ Fuller","year":"1997","unstructured":"Fuller, S. J., Davies, E. L., Gillespie-Brown, J., Sun, H., & Tonks, N. K. (1997). Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes.\u00a0Biochemical Journal, 323(Pt 2), 313\u2013319. https:\/\/doi.org\/10.1042\/bj3230313","journal-title":"Biochem J"},{"issue":"25","key":"10268_CR35","doi-asserted-by":"publisher","first-page":"14843","DOI":"10.1074\/jbc.270.25.14843","volume":"270","author":"MH Cobb","year":"1995","unstructured":"Cobb, M. H., & Goldsmith, E. J. (1995). How MAP kinases are regulated.\u00a0Journal of Biological Chemistry, 270(25), 14843\u201314846. https:\/\/doi.org\/10.1074\/jbc.270.25.14843","journal-title":"J Biol Chem"},{"issue":"20","key":"10268_CR36","doi-asserted-by":"publisher","first-page":"14373","DOI":"10.1016\/S0021-9258(19)49722-6","volume":"267","author":"R Seger","year":"1992","unstructured":"Seger, R., Ahn, N. G., Posada, J., Munar, E. S., Jensen, A. M., Cooper, J. A., et al. (1992). Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells.\u00a0Journal of Biological Chemistry, 267(20), 14373\u201314381.","journal-title":"J Biol Chem"},{"issue":"15","key":"10268_CR37","doi-asserted-by":"publisher","first-page":"11435","DOI":"10.1016\/S0021-9258(18)82142-1","volume":"268","author":"CF Zheng","year":"1993","unstructured":"Zheng, C. F., & Guan, K. L. (1993). Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2.\u00a0Journal of Biological Chemistry, 268(15), 11435\u201311439.","journal-title":"J Biol Chem"},{"issue":"45","key":"10268_CR38","doi-asserted-by":"publisher","first-page":"41755","DOI":"10.1074\/jbc.M106012200","volume":"276","author":"Y Matsubayashi","year":"2001","unstructured":"Matsubayashi, Y., Fukuda, M., & Nishida, E. (2001). Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells.\u00a0Journal of Biological Chemistry, 276(45), 41755\u201341760. https:\/\/doi.org\/10.1074\/jbc.M106012200","journal-title":"J Biol Chem"},{"issue":"4","key":"10268_CR39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s0092-8674(00)81189-7","volume":"93","author":"AV Khokhlatchev","year":"1998","unstructured":"Khokhlatchev, A. V., Canagarajah, B., Wilsbacher, J., Robinson, M., Atkinson, M., Goldsmith, E., et al. (1998). Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell, 93(4), 605\u2013615. https:\/\/doi.org\/10.1016\/s0092-8674(00)81189-7","journal-title":"Cell"},{"key":"10268_CR40","doi-asserted-by":"publisher","unstructured":"Maik-Rachline, G., Hacohen-Lev-Ran, A., & Seger, R. (2019). Nuclear ERK: Mechanism of translocation, substrates, and role in cancer. International Journal of Molecular Sciences, 20(5), doi:https:\/\/doi.org\/10.3390\/ijms20051194.","DOI":"10.3390\/ijms20051194"},{"issue":"3","key":"10268_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/emboj\/18.3.664","volume":"18","author":"A Brunet","year":"1999","unstructured":"Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S., & Pouyss\u00e9gur, J. (1999). Nuclear translocation of p42\/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. The EMBO Journal, 18(3), 664\u2013674. https:\/\/doi.org\/10.1093\/emboj\/18.3.664","journal-title":"The EMBO Journal"},{"issue":"23","key":"10268_CR42","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"OF Bueno","year":"2000","unstructured":"Bueno, O. F., De Windt, L. J., Tymitz, K. M., Witt, S. A., Kimball, T. R., Klevitsky, R., et al. (2000). The MEK1\u2013ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. The EMBO Journal, 19(23), 6341\u20136350. https:\/\/doi.org\/10.1093\/emboj\/19.23.6341","journal-title":"The EMBO Journal"},{"issue":"1","key":"10268_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm.1893","volume":"15","author":"K Lorenz","year":"2009","unstructured":"Lorenz, K., Schmitt, J. P., Schmitteckert, E. M., & Lohse, M. J. (2009). A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy.\u00a0Natural Medicines, 15(1), 75\u201383. https:\/\/doi.org\/10.1038\/nm.1893","journal-title":"Nat Med"},{"issue":"35","key":"10268_CR44","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0610906104","volume":"104","author":"NH Purcell","year":"2007","unstructured":"Purcell, N. H., Wilkins, B. J., York, A., Saba-El-Leil, M. K., Meloche, S., Robbins, J., et al. (2007). Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proceedings of the National Academy of Sciences of the United States of America, 104(35), 14074\u201314079. https:\/\/doi.org\/10.1073\/pnas.0610906104","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"19","key":"10268_CR45","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1161\/hc4401.099449","volume":"104","author":"M Flesch","year":"2001","unstructured":"Flesch, M., Margulies, K. B., Mochmann, H. C., Engel, D., Sivasubramanian, N., & Mann, D. L. (2001). Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation, 104(19), 2273\u20132276. https:\/\/doi.org\/10.1161\/hc4401.099449","journal-title":"Circulation"},{"issue":"4","key":"10268_CR46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmcc.2001.1348","volume":"33","author":"L Xiao","year":"2001","unstructured":"Xiao, L., Pimental, D. R., Amin, J. K., Singh, K., Sawyer, D. B., & Colucci, W. S. (2001). MEK1\/2-ERK1\/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. Journal of Molecular and Cellular Cardiology, 33(4), 779\u2013787. https:\/\/doi.org\/10.1006\/jmcc.2001.1348","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"10268_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bbrc.2008.01.099","volume":"368","author":"J Du","year":"2008","unstructured":"Du, J., Guan, T., Zhang, H., Xia, Y., Liu, F., & Zhang, Y. (2008). Inhibitory crosstalk between ERK and AMPK in the growth and proliferation of cardiac fibroblasts. Biochemical and Biophysical Research Communications, 368(2), 402\u2013407. https:\/\/doi.org\/10.1016\/j.bbrc.2008.01.099","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"11","key":"10268_CR48","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1161\/circulationaha.107.728865","volume":"117","author":"MI Kontaridis","year":"2008","unstructured":"Kontaridis, M. I., Yang, W., Bence, K. K., Cullen, D., Wang, B., Bodyak, N., et al. (2008). Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase\/mitogen-activated protein kinase and RhoA signaling pathways. Circulation, 117(11), 1423\u20131435. https:\/\/doi.org\/10.1161\/circulationaha.107.728865","journal-title":"Circulation"},{"issue":"1","key":"10268_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.0767-3981.2003.00212.x","volume":"18","author":"N Dzimiri","year":"2004","unstructured":"Dzimiri, N., Al-Bahnasi, K., & Al-Halees, Z. (2004). Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload. Fundamental & Clinical Pharmacology, 18(1), 39\u201344. https:\/\/doi.org\/10.1046\/j.0767-3981.2003.00212.x","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"5","key":"10268_CR50","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/ars.2009.2440","volume":"11","author":"LE Fried","year":"2009","unstructured":"Fried, L. E., & Arbiser, J. L. (2009). Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxidants & Redox Signaling, 11(5), 1139\u20131148. https:\/\/doi.org\/10.1089\/ars.2009.2440","journal-title":"Antioxidants & Redox Signaling"},{"issue":"18","key":"10268_CR51","doi-asserted-by":"publisher","first-page":"10663","DOI":"10.1111\/jcmm.15686","volume":"24","author":"Z Chi","year":"2020","unstructured":"Chi, Z., Le, T. P. H., Lee, S. K., Guo, E., Kim, D., Lee, S., et al. (2020). Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine \u03b3-lyase degradation. Journal of Cellular and Molecular Medicine, 24(18), 10663\u201310676. https:\/\/doi.org\/10.1111\/jcmm.15686","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10268_CR52","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1038\/ncomms7656","volume":"6","author":"VB Pillai","year":"2015","unstructured":"Pillai, V. B., Samant, S., Sundaresan, N. R., Raghuraman, H., Kim, G., Bonner, M. Y., et al. (2015). Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3. Nature Communications, 6, 6656. https:\/\/doi.org\/10.1038\/ncomms7656","journal-title":"Nature Communications"},{"key":"10268_CR53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cbi.2019.04.032","volume":"307","author":"Z Tan","year":"2019","unstructured":"Tan, Z., Liu, H., Song, X., Ling, Y., He, S., Yan, Y., et al. (2019). Honokiol post-treatment ameliorates myocardial ischemia\/reperfusion injury by enhancing autophagic flux and reducing intracellular ROS production. Chemico-Biological Interactions, 307, 82\u201390. https:\/\/doi.org\/10.1016\/j.cbi.2019.04.032","journal-title":"Chemico-Biological Interactions"},{"key":"10268_CR54","doi-asserted-by":"publisher","first-page":"3159801","DOI":"10.1155\/2018\/3159801","volume":"2018","author":"B Zhang","year":"2018","unstructured":"Zhang, B., Zhai, M., Li, B., Liu, Z., Li, K., Jiang, L., et al. (2018). Honokiol ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by reducing oxidative stress and apoptosis through activating the SIRT1-Nrf2 signaling pathway. Oxidative Medicine and Cellular Longevity, 2018, 3159801. https:\/\/doi.org\/10.1155\/2018\/3159801","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10268_CR55","doi-asserted-by":"publisher","first-page":"1640804","DOI":"10.1155\/2018\/1640804","volume":"2018","author":"XQ Wei","year":"2018","unstructured":"Wei, X. Q., Zhang, H. S., Wei, G. H., Zhang, J. G., Du, Y. Y., Tan, H. Y., et al. (2018). Honokiol protects against anti-\u03b21-adrenergic receptor autoantibody-induced myocardial dysfunction via activation of autophagy. Oxidative Medicine and Cellular Longevity, 2018, 1640804. https:\/\/doi.org\/10.1155\/2018\/1640804","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"6","key":"10268_CR56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1055\/s-2006-957957","volume":"62","author":"SK Tsai","year":"1996","unstructured":"Tsai, S. K., Huang, S. S., & Hong, C. Y. (1996). Myocardial protective effect of honokiol: an active component in Magnolia officinalis. Planta Medica, 62(6), 503\u2013506. https:\/\/doi.org\/10.1055\/s-2006-957957","journal-title":"Planta Medica"},{"issue":"5","key":"10268_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000028324","volume":"59","author":"SK Tsai","year":"1999","unstructured":"Tsai, S. K., Huang, C. H., Huang, S. S., Hung, L. M., & Hong, C. Y. (1999). Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin. Pharmacology, 59(5), 227\u2013233. https:\/\/doi.org\/10.1159\/000028324","journal-title":"Pharmacology"},{"issue":"2","key":"10268_CR58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejphar.2005.04.035","volume":"516","author":"H Zhai","year":"2005","unstructured":"Zhai, H., Nakade, K., Oda, M., Mitsumoto, Y., Akagi, M., Sakurai, J., et al. (2005). Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1\/2). European Journal of Pharmacology, 516(2), 112\u2013117. https:\/\/doi.org\/10.1016\/j.ejphar.2005.04.035","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10268_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41419-017-0166-5","volume":"9","author":"K Huang","year":"2018","unstructured":"Huang, K., Chen, Y., Zhang, R., Wu, Y., Ma, Y., Fang, X., et al. (2018). Honokiol induces apoptosis and autophagy via the ROS\/ERK1\/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death & Disease, 9(2), 157. https:\/\/doi.org\/10.1038\/s41419-017-0166-5","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10268_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3892\/ijmm.2019.4195","volume":"44","author":"X Peng","year":"2019","unstructured":"Peng, X., Li, X., Li, C., Yue, S., Huang, Y., Huang, P., et al. (2019). NMDA receptor activation inhibits the protective effect of BM-MSCs on bleomycin-induced lung epithelial cell damage by inhibiting ERK signaling and the paracrine factor HGF. International Journal of Molecular Medicine, 44(1), 227\u2013239. https:\/\/doi.org\/10.3892\/ijmm.2019.4195","journal-title":"International Journal of Molecular Medicine"},{"key":"10268_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119899","volume":"590","author":"J Wang","year":"2020","unstructured":"Wang, J., Yang, H., Li, Q., Wu, X., Di, G., Fan, J., et al. (2020). Novel nanomicelles based on rebaudioside A: A potential nanoplatform for oral delivery of honokiol with enhanced oral bioavailability and antitumor activity. International Journal of Pharmaceutics, 590, 119899. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119899","journal-title":"International Journal of Pharmaceutics"},{"issue":"21","key":"10268_CR62","doi-asserted-by":"publisher","first-page":"34082","DOI":"10.18632\/oncotarget.16133","volume":"8","author":"VB Pillai","year":"2017","unstructured":"Pillai, V. B., Kanwal, A., Fang, Y. H., Sharp, W. W., Samant, S., Arbiser, J., et al. (2017). Honokiol, an activator of sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice. Oncotarget, 8(21), 34082\u201334098. https:\/\/doi.org\/10.18632\/oncotarget.16133","journal-title":"Oncotarget"},{"key":"10268_CR63","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.freeradbiomed.2020.04.009","volume":"153","author":"L Wu","year":"2020","unstructured":"Wu, L., Liu, Y., Zhao, Y., Li, M., & Guo, L. (2020). Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Free Radical Biology & Medicine, 153, 140\u2013158. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.04.009","journal-title":"Free Radical Biology & Medicine"},{"issue":"4","key":"10268_CR64","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.3892\/mmr.2017.7098","volume":"16","author":"C Zeng","year":"2017","unstructured":"Zeng, C., Liang, B., Jiang, R., Shi, Y., & Du, Y. (2017). Protein kinase C isozyme expression in right ventricular hypertrophy induced by pulmonary hypertension in chronically hypoxic rats. Molecular Medicine Reports, 16(4), 3833\u20133840. https:\/\/doi.org\/10.3892\/mmr.2017.7098","journal-title":"Molecular Medicine Reports"},{"issue":"4","key":"10268_CR65","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.119.014311","volume":"10","author":"J Zhao","year":"2021","unstructured":"Zhao, J., Jiang, X., Liu, J., Ye, P., Jiang, L., Chen, M., et al. (2021). Dual-specificity phosphatase 26 protects against cardiac hypertrophy through TAK1. Journal of the American Heart Association, 10(4), e014311. https:\/\/doi.org\/10.1161\/jaha.119.014311","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"10268_CR66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.pharmtox.010909.105800","volume":"52","author":"E Reiter","year":"2012","unstructured":"Reiter, E., Ahn, S., Shukla, A. K., & Lefkowitz, R. J. (2012). Molecular mechanism of \u03b2-arrestin-biased agonism at seven-transmembrane receptors. Annual Review of Pharmacology and Toxicology, 52(1), 179\u2013197. https:\/\/doi.org\/10.1146\/annurev.pharmtox.010909.105800","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"9","key":"10268_CR67","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3390\/ijms20092164","volume":"20","author":"S Gallo","year":"2019","unstructured":"Gallo, S., Vitacolonna, A., Bonzano, A., Comoglio, P., & Crepaldi, T. (2019). ERK: A key player in the pathophysiology of cardiac hypertrophy. International Journal of Molecular Sciences, 20(9), 2164. https:\/\/doi.org\/10.3390\/ijms20092164","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10268_CR68","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1083\/jcb.148.6.1267","volume":"148","author":"KA DeFea","year":"2000","unstructured":"DeFea, K. A., Zalevsky, J., Thoma, M. S., D\u00e9ry, O., Mullins, R. D., & Bunnett, N. W. (2000). \u03b2-Arrestin\u2013dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated Erk1\/2. Journal of Cell Biology, 148(6), 1267\u20131282. https:\/\/doi.org\/10.1083\/jcb.148.6.1267","journal-title":"Journal of Cell Biology"},{"issue":"2","key":"10268_CR69","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/circresaha.110.231514","volume":"108","author":"I Kehat","year":"2011","unstructured":"Kehat, I., Davis, J., Tiburcy, M., Accornero, F., Saba-El-Leil, M. K., Maillet, M., et al. (2011). Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circulation Research, 108(2), 176\u2013183. https:\/\/doi.org\/10.1161\/circresaha.110.231514","journal-title":"Circulation Research"},{"issue":"1","key":"10268_CR70","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/cvr\/cvz331","volume":"117","author":"M Schnelle","year":"2021","unstructured":"Schnelle, M., Sawyer, I., Anilkumar, N., Mohamed, B. A., Richards, D. A., Toischer, K., et al. (2021). NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload. Cardiovascular Research, 117(1), 178\u2013187. https:\/\/doi.org\/10.1093\/cvr\/cvz331","journal-title":"Cardiovascular Research"},{"key":"10268_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s1937-6448(10)84003-1","volume":"284","author":"SP Barry","year":"2010","unstructured":"Barry, S. P., & Townsend, P. A. (2010). What causes a broken heart\u2013molecular insights into heart failure. International Review of Cell and Molecular Biology, 284, 113\u2013179. https:\/\/doi.org\/10.1016\/s1937-6448(10)84003-1","journal-title":"International Review of Cell and Molecular Biology"},{"issue":"19","key":"10268_CR72","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1128\/mcb.23.19.7030-7043.2003","volume":"23","author":"P Monje","year":"2003","unstructured":"Monje, P., Marinissen, M. J., & Gutkind, J. S. (2003). Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Molecular and Cellular Biology, 23(19), 7030\u20137043. https:\/\/doi.org\/10.1128\/mcb.23.19.7030-7043.2003","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"10268_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.31","volume":"7","author":"D Kami","year":"2016","unstructured":"Kami, D., Kitani, T., Kawasaki, T., & Gojo, S. (2016). Cardiac mesenchymal progenitors differentiate into adipocytes via Klf4 and c-Myc. Cell Death & Disease, 7(4), e2190. https:\/\/doi.org\/10.1038\/cddis.2016.31","journal-title":"Cell Death & Disease"},{"issue":"5","key":"10268_CR74","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian, E., & Karin, M. (2002). AP-1 as a regulator of cell life and death. Nature Cell Biology, 4(5), E131-136. https:\/\/doi.org\/10.1038\/ncb0502-e131","journal-title":"Nature Cell Biology"},{"issue":"6","key":"10268_CR75","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cellsig.2009.12.008","volume":"22","author":"E Shaulian","year":"2010","unstructured":"Shaulian, E. (2010). AP-1\u2013The Jun proteins: Oncogenes or tumor suppressors in disguise? Cellular Signalling, 22(6), 894\u2013899. https:\/\/doi.org\/10.1016\/j.cellsig.2009.12.008","journal-title":"Cellular Signalling"},{"issue":"1","key":"10268_CR76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mrrev.2009.01.001","volume":"682","author":"PW Vesely","year":"2009","unstructured":"Vesely, P. W., Staber, P. B., Hoefler, G., & Kenner, L. (2009). Translational regulation mechanisms of AP-1 proteins. Mutation Research, 682(1), 7\u201312. https:\/\/doi.org\/10.1016\/j.mrrev.2009.01.001","journal-title":"Mutation Research"},{"issue":"6","key":"10268_CR77","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/s0002-9440(10)61153-4","volume":"160","author":"JD Barrans","year":"2002","unstructured":"Barrans, J. D., Allen, P. D., Stamatiou, D., Dzau, V. J., & Liew, C. C. (2002). Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. The American Journal of Pathology, 160(6), 2035\u20132043. https:\/\/doi.org\/10.1016\/s0002-9440(10)61153-4","journal-title":"The American Journal of Pathology"},{"issue":"24","key":"10268_CR78","doi-asserted-by":"publisher","first-page":"11480","DOI":"10.1073\/pnas.88.24.11480","volume":"88","author":"H Schunkert","year":"1991","unstructured":"Schunkert, H., Jahn, L., Izumo, S., Apstein, C. S., & Lorell, B. H. (1991). Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proceedings of the National Academy of Sciences of the United States of America, 88(24), 11480\u201311484. https:\/\/doi.org\/10.1073\/pnas.88.24.11480","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"42","key":"10268_CR79","doi-asserted-by":"publisher","first-page":"35081","DOI":"10.1074\/jbc.C500353200","volume":"280","author":"P Monje","year":"2005","unstructured":"Monje, P., Hern\u00e1ndez-Losa, J., Lyons, R. J., Castellone, M. D., & Gutkind, J. S. (2005). Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. The Journal of Biological Chemistry, 280(42), 35081\u201335084. https:\/\/doi.org\/10.1074\/jbc.C500353200","journal-title":"The Journal of Biological Chemistry"},{"issue":"1\u20132","key":"10268_CR80","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11010-009-0061-1","volume":"327","author":"T Singal","year":"2009","unstructured":"Singal, T., Dhalla, N. S., & Tappia, P. S. (2009). Regulation of c-Fos and c-Jun gene expression by phospholipase C activity in adult cardiomyocytes. Molecular and Cellular Biology, 327(1\u20132), 229\u2013239. https:\/\/doi.org\/10.1007\/s11010-009-0061-1","journal-title":"Molecular and Cellular Biology"},{"issue":"1","key":"10268_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1161\/hy0102.100783","volume":"39","author":"T Omura","year":"2002","unstructured":"Omura, T., Yoshiyama, M., Yoshida, K., Nakamura, Y., Kim, S., Iwao, H., et al. (2002). Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine. Hypertension, 39(1), 81\u201386. https:\/\/doi.org\/10.1161\/hy0102.100783","journal-title":"Hypertension"},{"issue":"21","key":"10268_CR82","doi-asserted-by":"publisher","first-page":"8348","DOI":"10.1073\/pnas.83.21.8348","volume":"83","author":"NF Starksen","year":"1986","unstructured":"Starksen, N. F., Simpson, P. C., Bishopric, N., Coughlin, S. R., Lee, W. M., Escobedo, J. A., et al. (1986). Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proceedings of the National Academy of Sciences of the United States of America, 83(21), 8348\u20138350. https:\/\/doi.org\/10.1073\/pnas.83.21.8348","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10268_CR83","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1128\/mcb.10.7.3709","volume":"10","author":"T Jackson","year":"1990","unstructured":"Jackson, T., Allard, M. F., Sreenan, C. M., Doss, L. K., Bishop, S. P., & Swain, J. L. (1990). The c-myc proto-oncogene regulates cardiac development in transgenic mice. Molecular and Cellular Biology, 10(7), 3709\u20133716. https:\/\/doi.org\/10.1128\/mcb.10.7.3709","journal-title":"Molecular and Cellular Biology"},{"key":"10268_CR84","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yjmcc.2017.02.003","volume":"105","author":"MS Willis","year":"2017","unstructured":"Willis, M. S., Holley, D. W., Wang, Z., Chen, X., Quintana, M., Jensen, B. C., et al. (2017). BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility. Journal of Molecular and Cellular Cardiology, 105, 99\u2013109. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.02.003","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"12","key":"10268_CR85","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/hh2401.100742","volume":"89","author":"G Xiao","year":"2001","unstructured":"Xiao, G., Mao, S., Baumgarten, G., Serrano, J., Jordan, M. C., Roos, K. P., et al. (2001). Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circulation Research, 89(12), 1122\u20131129. https:\/\/doi.org\/10.1161\/hh2401.100742","journal-title":"Circulation Research"},{"key":"10268_CR86","doi-asserted-by":"publisher","unstructured":"Hou, N., Ye, B., Li, X., Margulies, K. B., Xu, H., Wang, X., et al. (2016). Transcription factor 7-like 2 mediates canonical Wnt\/\u03b2-catenin signaling and c-Myc upregulation in heart failure. Circulation. Heart Failure, 9(6), doi:https:\/\/doi.org\/10.1161\/circheartfailure.116.003010.","DOI":"10.1161\/circheartfailure.116.003010"},{"issue":"1","key":"10268_CR87","doi-asserted-by":"publisher","first-page":"13906","DOI":"10.1038\/s41598-018-32125-7","volume":"8","author":"JC Gawdzik","year":"2018","unstructured":"Gawdzik, J. C., Yue, M. S., Martin, N. R., Elemans, L. M. H., Lanham, K. A., Heideman, W., et al. (2018). sox9b is required in cardiomyocytes for cardiac morphogenesis and function. Scientific Reports, 8(1), 13906. https:\/\/doi.org\/10.1038\/s41598-018-32125-7","journal-title":"Scientific Reports"},{"issue":"10","key":"10268_CR88","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1210\/en.2017-00416","volume":"158","author":"SM Brown","year":"2017","unstructured":"Brown, S. M., Smith, C. E., Meuth, A. I., Khan, M., Aroor, A. R., Cleeton, H. M., et al. (2017). Dipeptidyl peptidase-4 inhibition with saxagliptin ameliorates angiotensin II-induced cardiac diastolic dysfunction in male mice. Endocrinology, 158(10), 3592\u20133604. https:\/\/doi.org\/10.1210\/en.2017-00416","journal-title":"Endocrinology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10268-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-022-10268-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10268-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:48:47Z","timestamp":1670262527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-022-10268-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10268"],"URL":"https:\/\/doi.org\/10.1007\/s12265-022-10268-3","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"6 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols in this study were in accordance with the Helsinki Declaration of 1975, as revised in 2000, and were approved by the Institutional Animal Care and Use Committee of Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine (SHDSYY-0095). Informed consent was obtained from all participants. Institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}